NCT00541060

Brief Summary

Alteration of the post- eruptive enamel microstructure due to a mutation of a gene coding for a matrix protein could increase the susceptibility of the enamel to caries after tooth eruption. To identify in young patients with severe caries incidence, the occurrence of mutations in several candidate genes which result in an alteration of the enamel microstructure that could explain the high caries susceptibility of the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
390

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 4, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 8, 2007

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

2.1 years

First QC Date

October 4, 2007

Last Update Submit

March 2, 2026

Conditions

Keywords

caries susceptibility,enamel matrix,candidate genes,mutation

Outcome Measures

Primary Outcomes (1)

  • the finding of a mutation on the candidates genes not resulting in an amelogenesis imperfecta phenotype but associated to a severe caries phenotype

    baseline, 6 months

Secondary Outcomes (1)

  • If a direct relation between a mutation and a severe caries phenotype was shown, all the classical approaches, prevention protocols and treatments of caries would need to be reconsidered.

    6 months

Study Arms (2)

A

ACTIVE COMPARATOR

250 young patients presenting several carious lesions

Genetic: mutation

B

PLACEBO COMPARATOR

160 young adults totally caries free

Genetic: mutation

Interventions

mutationGENETIC

a mutation of a gene coding

Also known as: a mutation of a gene coding
AB

Eligibility Criteria

Age2 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients : presenting at least 3 active carious lesions aged 2 to 16 years old, written informed consent
  • Volunteers : young adults 18 to 30 years old totally caries free

You may not qualify if:

  • patients with systemic or enamel pathologies such as amelogenesis imperfecta
  • osteogenesis imperfecta
  • hypophosphatemia
  • hypodermal dysplasia
  • syndrome of Prader Willi
  • Fluoroses
  • toxic enamel dysplasia
  • pregnancy or breast-feeding
  • HYPOSIALORRHEA
  • immunodepression status
  • chronicle diseases
  • anorexia or bulimia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Bretonneau

Paris, 75018, France

Location

Related Publications (1)

  • Gasse B, Grabar S, Lafont AG, Quinquis L, Opsahl Vital S, Davit-Beal T, Moulis E, Chabadel O, Hennequin M, Courson F, Droz D, Vaysse F, Laboux O, Tassery H, Al-Hashimi N, Boillot A, Carel JC, Treluyer JM, Jeanpierre M, Beldjord C, Sire JY, Chaussain C. Common SNPs of AmelogeninX (AMELX) and dental caries susceptibility. J Dent Res. 2013 May;92(5):418-24. doi: 10.1177/0022034513482941. Epub 2013 Mar 22.

MeSH Terms

Conditions

Dental Caries

Interventions

Mutation

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Genetic VariationGenetic Phenomena

Study Officials

  • Catherine Miller, MCU-PH

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2007

First Posted

October 8, 2007

Study Start

October 1, 2007

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations